CVRx Inc investor relations material

CVRx develops and commercializes neuromodulation solutions for patients with heart failure. CVRx's first product, Barostim, is a investigational device that delivers low-energy electrical stimulation to the left ventricle through cardiac leads inserted into veins that leave the left ventricle.